Segui
mario p colombo
mario p colombo
Istituto Nazionale Tumori, Milano, Italy
Email verificata su istitutotumori.mi.it
Titolo
Citata da
Citata da
Anno
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
11200*2021
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
V Bronte, S Brandau, SH Chen, MP Colombo, AB Frey, TF Greten, ...
Nature communications 7 (1), 1-10, 2016
18232016
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
G Gallina, L Dolcetti, P Serafini, C De Santo, I Marigo, MP Colombo, ...
The Journal of clinical investigation 116 (10), 2777-2790, 2006
9202006
Interleukin-12 in anti-tumor immunity and immunotherapy
MP Colombo, G Trinchieri
Cytokine & growth factor reviews 13 (2), 155-168, 2002
8442002
The terminology issue for myeloid-derived suppressor cells
DI Gabrilovich, V Bronte, SH Chen, MP Colombo, A Ochoa, ...
Cancer research 67 (1), 425-425, 2007
8272007
Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.
P Paglia, C Chiodoni, M Rodolfo, MP Colombo
The Journal of experimental medicine 183 (1), 317-322, 1996
7771996
Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection
C Guiducci, AP Vicari, S Sangaletti, G Trinchieri, MP Colombo
Cancer research 65 (8), 3437-3446, 2005
6192005
Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry
SG Priori, M Gasparini, C Napolitano, P Della Bella, AG Ottonelli, ...
Journal of the American College of Cardiology 59 (1), 37-45, 2012
6032012
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice
V Bronte, P Serafini, C De Santo, I Marigo, V Tosello, A Mazzoni, ...
The Journal of Immunology 170 (1), 270-278, 2003
5852003
The intriguing role of polymorphonuclear neutrophils in antitumor reactions
E Di Carlo, G Forni, PL Lollini, MP Colombo, A Modesti, P Musiani
BLOOD-NEW YORK- 97 (2), 339-345, 2001
5322001
p50 nuclear factor-κB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance
A Saccani, T Schioppa, C Porta, SK Biswas, M Nebuloni, L Vago, ...
Cancer research 66 (23), 11432-11440, 2006
5182006
Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy
MP Colombo, S Piconese
Nature Reviews Cancer 7 (11), 880-887, 2007
4702007
Classification of current anticancer immunotherapies
L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqu, L Senovilla, ...
Oncotarget 5 (24), 12472, 2014
4632014
Triggering of OX40 (CD134) on CD4+ CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR
B Valzasina, C Guiducci, H Dislich, N Killeen, AD Weinberg, MP Colombo
Blood 105 (7), 2845-2851, 2005
4542005
Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake
S Todryk, AA Melcher, N Hardwick, E Linardakis, A Bateman, ...
The Journal of Immunology 163 (3), 1398-1408, 1999
4491999
CD4+ CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction
G Gri, S Piconese, B Frossi, V Manfroi, S Merluzzi, C Tripodo, A Viola, ...
Immunity 29 (5), 771-781, 2008
4352008
The promyelocytic leukemia zinc finger–microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms
F Felicetti, MC Errico, L Bottero, P Segnalini, A Stoppacciaro, M Biffoni, ...
Cancer research 68 (8), 2745-2754, 2008
4332008
Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti–interleukin 10 receptor antibody
AP Vicari, C Chiodoni, C Vaure, S At-Yahia, C Dercamp, F Matsos, ...
The Journal of experimental medicine 196 (4), 541-549, 2002
4262002
OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection
S Piconese, B Valzasina, MP Colombo
The Journal of experimental medicine 205 (4), 825-839, 2008
4192008
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25 into CD25+ T regulatory cells
A Curti, S Pandolfi, B Valzasina, M Aluigi, A Isidori, E Ferri, V Salvestrini, ...
Blood 109 (7), 2871-2877, 2007
4172007
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20